代谢功能障碍相关的肥胖性肝病和肉症:习惯性食物的影响
Naiade S Almeida1, Raquel Rocha2, Carla Daltro2
1Post-Graduated Program in Medicine and Heath (PPGMS), Bahia Medicine School, Universidade Federal da Bahia, Salvador 40110-060, Bahia, Brazil.
Diagnostics (Basel, Switzerland)
|November 13, 2025
概括
在代谢功能障碍相关的脂肪性肝病 (MASLD) 患者中,低摄入量与可能的肉症有关. 需要进一步的研究,以探索饮食对MASLD. sarcopenia的影响.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 营养科学 营养科学
- 老年病的医生 老年病的医生
背景情况:
- 萨科佩尼亚与诸如代谢功能障碍相关的脂肪性肝病 (MASLD) 等肝脏疾病有关.
- MASLD的进展包括肥胖症,肥胖肝炎,纤维化,肝硬化和肝细胞癌.
- 饮食因素影响MASLD,但它们与MASLD中肉症的联系尚未得到充分研究.
研究的目的:
- 调查MASLD患者习惯性食物消费和肉症之间的关联.
- 为了探索MASLD患者的饮食模式和营养摄入量,有和没有sarcopenia.
主要方法:
- 对MASLD门诊患者的横截面研究 (n=76).
- 使用2019年EWGSOP2标准评估的肉类.
- 通过使用多源方法 (MSM) 软件的24小时回忆来评估饮食摄入量.
- 通过超声波诊断出肥胖症;使用FIB-4指数评估肝纤维化.
主要成果:
- 两名患者 (2.6%) 患有肉类;27.6% (n=21) 患有可能的肉类 (肌肉强度低).
- 可能患有肉症的群体与没有肉症的群体相比,摄入量较低 (p=0.04).
- 一般来说,MASLD患者的,能量和蛋白质摄入量较低.
结论:
- 很大一部分MASLD患者表现出可能的肉症.
- 较低的摄入量与MASLD中可能发生的肉症有关.
- 需要进一步研究MASLD中肉症的饮食干预措施.
相关概念视频
01:24Overview of Lipid Metabolism
4.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.8K
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
163
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
163
01:19Overview of Carbohydrate Metabolism
3.2K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.2K
01:24Metabolic States of the Body: Fasting and Starvation
2.7K
During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
2.7K
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
171
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
171
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
208
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
208